PBE ETF holdings (NYSE) | MetaTrader

Abrir gráfico completo Full chart

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

Invesco Private Prime Fund 26.78 M 26.78 M 10.18%

ILMN Illumina, Inc. 14.94 M 103.20 K 5.68%

GILD Gilead Sciences, Inc. 14.73 M 103.77 K 5.60%

AMGN Amgen Inc. 13.29 M 38.88 K 5.06%

BIIB Biogen Inc. 13.22 M 73.52 K 5.03%

UTHR United Therapeutics Corp. 12.79 M 27.24 K 4.86%

REGN Regeneron Pharmaceuticals, Inc. 12.66 M 17.07 K 4.81%

INCY Incyte Corp. 12.24 M 122.36 K 4.66%

Invesco Private Government Fund 10.31 M 10.31 M 3.92%

F

FOLD Amicus Therapeutics, Inc. 10.25 M 716.94 K 3.90%

ALNY Alnylam Pharmaceuticals, Inc. 10.12 M 29.94 K 3.85%

Dynavax Technologies Corp. 9.60 M 619.80 K 3.65%

QGEN Qiagen N.V. 8.06 M 150.20 K 3.07%

MNKD MannKind Corp. 7.99 M 1.38 M 3.04%

IONS Ionis Pharmaceuticals, Inc. 7.47 M 90.30 K 2.84%

ACAD Acadia Pharmaceuticals Inc. 7.46 M 296.68 K 2.84%

RPRX Royalty Pharma PLC 7.43 M 178.38 K 2.83%

CPRX Catalyst Pharmaceuticals, Inc. 7.33 M 301.60 K 2.79%

BMRN BioMarin Pharmaceutical Inc. 7.22 M 127.76 K 2.75%

TECH Bio-Techne Corp. 7.16 M 111.68 K 2.72%

1
2

Notícias

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies